FEBRILE NEUTROPENIA: WHAT IS IMPORTANT FOR A THERAPIST TO KNOW

DOI: https://doi.org/10.29296/25877305-2019-03-18
Download full text PDF
Issue: 
3
Year: 
2019

V. Cherepanova(1), MD; Z. Mikhailova(2), MD; V. Sinkova(3) 1-City Clinical Hospital Thirty-Three, Leninsky District, Nizhny Novgorod 2-City Clinical Hospital Thirty-Eight, Nizhny Novgorod District, Nizhny Novgorod 3-Bor Central District Hospital, Bor

The paper considers the etiology, classification, and differential diagnosis of chronic neutropenia. It also discusses the drugs prescribed by practicing therapists to treat various somatic diseases as the cause of drug (hapten)-induced agranulocytosis. The authors also give an algorithm for the diagnosis of acquired neutropenia and a protocol for the treatment of febrile neutropenia in non-cancer patients.

Keywords: 
therapy
neutropenia
diagnosis
treatment of febrile neutropenia



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Papadaki H., Eliopoulos G. An overview on the diagnosis, classification and differential diagnosis of chronicneutropenias // Haema. – 2002; 5: 39–49.
  2. Boocock G., Morrison J., Popovic M. et al. Mutations in SBDS are associated with Schwachman-Diamond syndrome// Nat. Genet. – 2003; 33 (1): 97–101.
  3. Newburger P. Autoimmune and Other Acquired Neutropenias // Hematology Am. Soc. Hematol. Educ. Program. – 2016; 1: 38–42.
  4. Dragomiretskaja N., Podzolkov B. Sluchaj agranulotsitoza, vyzvannogo priemom diklofenaka // Vrach. – 2013; 2: 49–53 [Dragomiretskaya N., Podzolkov V. A case of diclofenac-induced agranulocytosis // Vrach. – 2013; 2: 49–53 (in Russ.)].
  5. Kardiologija: natsional'noe rukovodstvo. Pod red. Ju.N. Belenkova, R.G. Oganova / M.: GEOTAR-Media, 2008; 1232 s. [Kardiologiya: natsional’noye rukovodstvo. Eds. Yu.N. Belenkov, R.G. Oganov / M.: GEOTAR-Media, 2008; 1232 p. (in Russ.)].
  6. Tabeeva R.G. Neprostye prostye anal'getiki, ili o chem nado pomnit' pri vybore anal'getika // RMZh. – 2013; 21 (10): 470–5 [Tabeyeva R.G. Neprostyye prostyye anal’getiki, ili o chem nado pomnit’ pri vybore anal’getika // Russkiy meditsinskiy zhurnal. – 2013; 21 (10): 470–5 (in Russ.)].
  7. Registr lekarstvennyh sredstv Rossii RLS Entsiklopedija lekarstv. – 25-j vyp. Gl. red. G.L. Vyshkovskij / M.: VEDANTA, 2016; 1288 s. [Registr lekarstvennykh sredstv Rossii RLS Entsiklopediya lekarstv. Ed. G.L. Vyshkovskiy / M.: VEDANTA, 2016; 1288 p. (in Russ.)].
  8. Andrade S., Bartels D., Lange R. et al. Safety of metamizole: a systematic review of the literature // J. Clin. Pharm. Ther. – 2016; 41 (5): 459–77.
  9. Ushkalova E.A. Profil' bezopasnosti anal'getikov-antipiretikov v pediatrii // RMZh. – 2014; 22 (21): 1526–9 [Ushkalova Ye.A. Profil’ bezopasnosti anal’getikov-antipiretikov v pediatrii // Russkiy meditsinskiy zhurnal. – 2014; 22 (21): 1526–9 (in Russ.)].
  10. Ushkalova E.A., Zyrjanov S.K., Pereverzev A.P. Klinicheskaja farmakologija nesteroidnyh protivovospalitel'nyh sredstv: uchebnoe posobie / M.: MIA, 2018; 368 s. [Ushkalova Ye.A., Zyryanov S.K., Pereverzev A.P. Klinicheskaya farmakologiya nesteroidnykh protivovospalitel’nykh sredstv: uchebnoye posobiye / M.: MIA, 2018; 368 p. (in Russ.)].
  11. Ganapiev A.A., Afanas'ev B.V. Gematologija: rukovodstvo dlja vrachej. Pod red. N.N. Mamaeva. 2-e izd., dop. i ispr. / SPb: SpetsLit, 2011; 615 s. [Ganapiyev A.A., Afanas’yev B.V. Gematologiya: rukovodstvo dlya vrachey. Pod red. N.N. Mamayeva. 2-ye izd., dop. i ispr. / SPb: SpetsLit, 2011; 615 p. (in Russ.)].
  12. Newburger P., Dale D. Evaluation and Management of Patients with Isolated Neutropenia // Semin. Hemat. – 2013; 50 (3): 198–306.
  13. Podjasek J., Abraham R. Autoimmune Cytopenias In Common Variable Immunodeficiency // Front. Immunol. – 2012; 3: 189.
  14. Orlova R.V., Chubenko V.A. Febril'naja nejtropenija, infektsionno-toksicheskij shok // Prakt. onkol. – 2006; 7 (2): 69–76 [Orlova R.V., Chubenko V.A. Febril’naya neytropeniya, infektsionno-toksicheskiy shok // Prakticheskaya onkologiya. – 2006; 7 (2): 69–76 (in Russ.)].
  15. Sakaeva D.D., Orlova R.V., Rykov I.V. i dr. Prakticheskie rekomendatsii po lecheniju infektsionnyh oslozhnenij febril'noj nejtropenii i naznacheniju koloniestimulirujuschih faktorov u onkologicheskih bol'nyh // Zlokachestvennye opuholi: Prakticheskie rekomendatsii RUSSCO#3s2. – 2017; 7: 486–95 [Sakayeva D.D., Orlova R.V., Rykov I.V. i dr. Prakticheskiye rekomendatsii po lecheniyu infektsionnykh oslozhneniy febril’noy neytropenii i naznacheniyu koloniyestimuliruyushchikh faktorov u onkologicheskikh bol’nykh // Zlokachestvennyye opukholi: Prakticheskiye rekomendatsii RUSSCO#3s2. – 2017; 7: 486–95 (in Russ.)]. DOI:10.18027/2224–5057–2017–7–3s2–486–495.
  16. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Prevention and Treatment of Cancer-Related Infections, 2016; v. 2; 154 r.
  17. Andres E., Mourot-Cottet R., Maloisel F. et al. History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs // J. Clin. Med. – 2017; 6 (10): 92.
  18. Mourot-Cottet R., Maloisel F., Severac F. et al. Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases // Drugs – Real World Outcomes. – 2016; 3 (4): 393–9.
  19. Butov M.A. Propedevtika vnutrennih boleznej: uchebnoe posobie. 2-e izd. / M.: FORUM: INFRA-M, 2016; 512 s. [Butov M.A. Propedevtika vnutrennikh bolezney: uchebnoye posobiye. 2 izd. / M.: FORUM: INFRA-M, 2016; 512 s. (in Russ.)].
  20. Zatolochina K.E., Kazakov A.S., Kolesnikova E.Ju. i dr. Rivaroksaban: sravnitel'nyj analiz nezhelatel'nyh reaktsij v Rossijskoj i mezhdunarodnoj bazah dannyh // Klin. med. – 2017; 95 (5): 451–6 [Zatolochina K.E., Kazakov A.S., Kolesnikova E.Yu. et al. Rivaroxaban: comparative analysis of information on adverse reactions from russian and international databases // Klinicheskaya meditsina. – 2017; 95 (5): 451–6 (in Russ.)].